Trial Outcomes & Findings for Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS) (NCT NCT05021133)

NCT ID: NCT05021133

Last Updated: 2026-01-08

Results Overview

Number of participants completed Tele-Navi LCS,

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

22 participants

Primary outcome timeframe

30 days

Results posted on

2026-01-08

Participant Flow

Of 22 enrolled participants, 2 withdrew prior to the baseline survey.

Participant milestones

Participant milestones
Measure
Tele-Navi LCS
Tele-Navi of LCS includes: telehealth coaching from a Tele-Navigator for patients undergoing LCS using a video or telephone call
Overall Study
STARTED
20
Overall Study
COMPLETED
20
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Tele-Navi LCS
n=20 Participants
Tele-Navi of LCS includes telehealth coaching from a Tele-Navigator for patients undergoing LCS using a video or telephone call
Age, Continuous
60.5 years
n=18 Participants
Sex: Female, Male
Female
12 Participants
n=18 Participants
Sex: Female, Male
Male
8 Participants
n=18 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
n=18 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
16 Participants
n=18 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=18 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=18 Participants
Race (NIH/OMB)
Asian
0 Participants
n=18 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
n=18 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=18 Participants
Race (NIH/OMB)
White
17 Participants
n=18 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=18 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
n=18 Participants
Region of Enrollment
United States
20 participants
n=18 Participants

PRIMARY outcome

Timeframe: 30 days

Number of participants completed Tele-Navi LCS,

Outcome measures

Outcome measures
Measure
Tele-Navi LCS
n=20 Participants
Tele-Navi of LCS includes: telehealth coaching from a Tele-Navigator for patients undergoing LCS using a video or telephone call
Completion of Tele-Navi LCS
20 Participants

SECONDARY outcome

Timeframe: 180 days

Population: 2 participants moved out from the healthcare system

Number of participants who received a low-dose CT (LDCT) for LCS follow-up

Outcome measures

Outcome measures
Measure
Tele-Navi LCS
n=18 Participants
Tele-Navi of LCS includes: telehealth coaching from a Tele-Navigator for patients undergoing LCS using a video or telephone call
Completion of Follow-up LCS
10 Participants

Adverse Events

Tele-Navi LCS

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Mayuko Ito Fukunaga

UMass Chan Medical School

Phone: 5088561975

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place